LOVATO, Ornella
 Distribuzione geografica
Continente #
NA - Nord America 3.527
EU - Europa 2.797
AS - Asia 1.837
SA - Sud America 181
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 50
OC - Oceania 17
Totale 8.477
Nazione #
US - Stati Uniti d'America 3.418
RU - Federazione Russa 1.012
SG - Singapore 655
GB - Regno Unito 590
CN - Cina 585
IT - Italia 391
VN - Vietnam 173
SE - Svezia 157
DE - Germania 147
BR - Brasile 144
FR - Francia 135
HK - Hong Kong 127
FI - Finlandia 110
IE - Irlanda 92
BD - Bangladesh 83
CA - Canada 57
KR - Corea 49
IN - India 41
NL - Olanda 32
TR - Turchia 26
UA - Ucraina 24
BE - Belgio 20
JP - Giappone 20
MX - Messico 20
PL - Polonia 16
AU - Australia 15
ID - Indonesia 14
ES - Italia 12
BJ - Benin 11
ZA - Sudafrica 11
AR - Argentina 9
AT - Austria 8
EC - Ecuador 8
IQ - Iraq 8
IR - Iran 8
NG - Nigeria 8
DK - Danimarca 7
CO - Colombia 6
CR - Costa Rica 6
HN - Honduras 6
LT - Lituania 6
CL - Cile 5
CW - ???statistics.table.value.countryCode.CW??? 5
HR - Croazia 5
IL - Israele 5
PK - Pakistan 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
CY - Cipro 4
CZ - Repubblica Ceca 4
EG - Egitto 4
HU - Ungheria 4
NI - Nicaragua 4
PH - Filippine 4
PT - Portogallo 4
SV - El Salvador 4
TW - Taiwan 4
UZ - Uzbekistan 4
KE - Kenya 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
CG - Congo 1
ET - Etiopia 1
FJ - Figi 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NC - Nuova Caledonia 1
NE - Niger 1
Totale 8.406
Città #
Ashburn 622
Southend 461
Moscow 384
Singapore 356
San Jose 298
Chandler 242
Dallas 241
Ann Arbor 189
Jacksonville 179
Woodbridge 176
Beijing 140
New York 124
Hong Kong 123
Verona 112
Council Bluffs 91
Dublin 91
The Dalles 65
Los Angeles 63
Ho Chi Minh City 56
Munich 49
Houston 43
Wilmington 43
Jinan 39
Milan 37
Hanoi 36
Helsinki 35
Santa Clara 35
São Paulo 33
Lawrence 31
Princeton 31
Shenyang 31
Nanjing 30
Redmond 30
Buffalo 28
Orem 27
Frankfurt am Main 23
Hebei 23
Tianjin 22
Bologna 21
Columbus 21
Boardman 20
Brussels 20
Toronto 20
Turku 20
Manchester 18
Tokyo 18
Brooklyn 17
Changsha 17
Ningbo 17
Chennai 16
Rome 15
Seoul 15
London 14
Warsaw 14
Chicago 13
Haiphong 13
Zhengzhou 13
Dearborn 12
Denver 12
Cotonou 11
Guangzhou 11
Montreal 11
Falls Church 10
Haikou 10
Hangzhou 10
Phoenix 10
Melbourne 9
Nanchang 9
Redondo Beach 9
Amsterdam 8
Mexico City 8
Naples 8
Norwalk 8
Paris 8
Seattle 8
Stockholm 8
Annandale 7
Atlanta 7
Charlotte 7
Falkenstein 7
Jiaxing 7
Johannesburg 7
Lagos 7
Lappeenranta 7
Basingstoke 6
Da Nang 6
McKinney 6
Mestre 6
San Francisco 6
San José 6
Taiyuan 6
The Bronx 6
Venice 6
Washington 6
Auburn Hills 5
Boston 5
Düsseldorf 5
Fremont 5
Fuzhou 5
Jakarta 5
Totale 5.287
Nome #
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 309
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 285
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 279
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 277
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 268
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 266
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 260
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 259
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 252
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 249
BCR-signaling profiles associated with prognosis and progression in B-CLL 247
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 243
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 242
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 234
BCR-signaling profiles associated with prognosis and progression in B-CLL 230
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 223
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 219
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 202
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 202
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 196
SIGNALING NETWORK IN T-CELL LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A SINGLE-CELL MULTI-PARAMETRIC PHOSPHO-FLOW CYTOMETRY STUDY 196
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 191
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 189
Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells 186
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 183
Targeting survival signaling pathways in chronic lymphocytic leukemia via anti-CD20 antibodies 181
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 173
Anti-CD20 monoclonal antibodies down modulate the B-cell receptor signaling in chronic lymphocytic leukemia: a phosho-specific flow cytometry study 172
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 168
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia 162
Multi-parametric phospho-flow cytometry in T-call Acute Lymphoblastic Leukemia 156
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 150
MODULATION OF THE B-CELL RECEPTOR SIGNALING BY LENALIDOMIDE AND OFATUMUMAB IN CHRONIC LYMPHOCYTIC LEUKEMIA 149
CATALASE BLOCKING INDUCES APOPTOSIS AND POTENTIATES VENETOCLAX-INDUCED CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 130
CAT RS1001179 SINGLE NUCLEOTIDE POLYMORPHISM IDENTIFIES AN AGGRESSIVE CLINICAL BEHAVIOR IN CHRONIC LYMPHOCYTIC LEUKEMIA 126
null 119
A phospho-specific flow cytometry study reveals the impact of BCR signaling activation in mantle cell lymphoma progression and therapy 106
BCR signaling activity stratifies patents with MCL with divergent clinical outcome 105
PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF THE B-CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA 103
ACTIVATION OF BCR SIGNALING REWIRES THE RESPONSE OF BCR-ASSOCIATED KINASES TO IBRUTINIB IN MANTLE CELL LYMPHOMA CELLS 95
GENETIC AND EPIGENETIC MECHANISMS REGULATING CATALASE EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 85
B-CELL RECEPTOR SIGNALING PROFILES IDENTIFY SUBSETS OF MANTLE CELL LYMPHOMA PATIENTS WITH DIFFERENT CLINICAL OUTCOMES 81
Association of genetic polymorphisms with differential catalase gene expression in prognostic groups of chronic lymphocytic leukemia patients. 73
null 70
Regulation of catalase expression in chronic lymphocytic leukemia cells. 66
CATALASE EXPRESSION IN LEUKEMIA CELLS IS CONTROLLED BY GENETIC AND EPIGENETIC MECHANISMS 61
Fluorescent cell barcoding and phospho-specific flow cytometry characterize B-cell receptor signaling profiles associated with different clinical outcome in mantle cell lymphoma 59
Totale 8.477
Categoria #
all - tutte 24.352
article - articoli 7.029
book - libri 0
conference - conferenze 17.323
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022161 0 0 0 0 22 7 6 16 12 12 32 54
2022/2023676 39 81 51 161 54 156 5 28 75 5 13 8
2023/2024396 18 27 26 28 44 94 17 18 8 24 57 35
2024/2025893 38 53 22 140 38 36 57 38 156 64 87 164
2025/20263.538 177 142 203 448 1.055 249 295 180 278 213 154 144
2026/2027895 58 153 220 461 3 0 0 0 0 0 0 0
Totale 8.477